2020-04-01

09:54 PM • MHRA (UK gov)Managing clinical trials during Coronavirus (COVID-19)

09:32 PM • European Medicines Agency (EMA)Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic

09:14 PM • Fierce BiotechCRISPR Therapeutics braces for 'severe impact' from COVID-19 crisis

09:01 PM • STATAs Covid-19 spreads, disruptions to clinical trial and drug development accelerate

08:57 PM • US FDAFDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

08:43 PM • MedscapeCOVID-19 Slows Drug Studies, Curbs Clinical Trials

2020-03-30

05:32 PM • CNBCJohnson & Johnson says human testing of its coronavirus vaccine to begin by September

2020-03-29

08:23 PM • Medscape'Stealth Transmission' of COVID-19 Demands Widespread Mask Usage

07:56 PM • U.S. Surgeon GeneralSeriously people- STOP BUYING MASKS! They are NOT effective in preventing general public from catching #Coronavirus, but if healthcare providers can’t get them to care for sick patients, it puts them and our communities at risk!

07:41 PM • The BMJPhysical interventions to interrupt or reduce the spread of respiratory viruses: systematic review

07:07 PM • New York TimesMore Americans Should Probably Wear Masks for Protection

07:03 PM • ScienceWould everyone wearing face masks help us slow the pandemic?

04:52 PM • The Telegraph - LondonSocial distancing: new study suggests two metres is not enough

04:41 PM • EPIDEMIC with Dr. Celine Gounder and Ronald KlainBONUS / A False Dichotomy: Airborne versus Droplet / Roxanne Khamsi and Lydia Bourouiba

04:07 PM • JAMA-Journal of American Medical AssociationTurbulent Gas Clouds and Respiratory Pathogen Emissions

2020-03-23

09:47 PM • US FDASearch Orphan Drug Designations and Approvals

09:36 PM • MarketWatchGilead Sciences, 'flooded' by demand for remdesivir, halts compassionate use

09:32 PM • STATGilead pauses access to experimental Covid-19 drug due to ‘overwhelming demand’

09:24 PM • New York TimesCoronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access

06:30 PM • New York TimesLost Sense of Smell May Be Peculiar Clue to Coronavirus Infection

06:23 PM • ENT UKLoss of sense of smell as marker of COVID-19 infection

06:13 PM • Business InsiderIf you've lost your sense of smell or taste, you could be a 'hidden carrier' of the coronavirus

2020-03-20

02:41 PM • The Daily BeastImperial College Scientist Who Inspired the U.S. and U.K. Coronavirus Lockdowns Is in Self-Isolation

02:31 PM • The Washington PostA chilling scientific paper helped upend U.S. and U.K. coronavirus strategies

01:20 PM • Financial TimesThat Imperial coronavirus report, in detail

01:07 PM • New York TimesBehind the Virus Report That Jarred the U.S. and the U.K. to Action

03:06 AM • Duke-Margolis Center for Health PolicyAdvancing Treatments to Save Lives and Reduce the Risk of COVID-19

2020-03-13

11:19 PM • ScienceDid an experimental drug help a U.S. coronavirus patient?

10:59 PM • Wall Street JournalExperimental Drug Helps Some Americans Ride Out Coronavirus, NIH Doctor Says

10:57 PM • Investor's Business DailyGilead Pops After Coronavirus Drug Helps Cruise Ship Patients In Japan

04:24 PM • WestfaironlineRegeneron seeks a protect-and-treat antidote for COVID-19

04:23 PM • NASDAQA Stock That Defies Conventions & Corona - Regeneron Pharma

03:57 PM • CNBCRegeneron CEO hopes to have coronavirus treatment ready for human testing possibly by this summer

03:54 PM • NBCA New York biotech company is working to make an antibody treatment for the coronavirus

2020-03-11

04:03 PM • CNN70 of 92 coronavirus cases in Massachusetts linked to Biogen employees after biotech firm's Boston meeting

03:54 PM • Boston GlobeHow the Biogen leadership conference in Boston spread the coronavirus

2020-03-06

07:51 PM • Endpoints NewsAstraZeneca's Imfinzi fails bladder cancer trial — in patient population covered by FDA's 2017 accelerated approval

07:46 PM • Targeted OncologyOS End Points Not Met With Durvalumab/Tremelimumab in Phase III Bladder Cancer Trial

2020-03-05

12:51 AM • New York TimesDoctors Try 1st CRISPR Editing in the Body for Blindness

12:42 AM • BioPharma DiveIn a CRISPR first, Editas therapy used to fix genes in the body

12:39 AM • NASDAQEditas and Allergan Make Gene-Editing History With First Treatment of Blindness Drug

2020-03-04

04:43 PM • Genetic Engineering & Biotechnology NewsCoronavirus: Takeda Pursues Plasma-Derived Treatment; Alnylam and Vir Eye siRNA Therapy

04:39 PM • Seeking AlphaVir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19

2020-03-03

09:23 PM • US FDAFDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma

09:11 PM • FiercePharmaSanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling

09:10 PM • Endpoints NewsEnding a grueling 10-year drought, Sanofi finally wins an OK for an in-house cancer drug

08:34 PM • New York TimesShareholder Calls for Separation of J&J's CEO and Chairman Roles

08:32 PM • FiercePharmaCiting J&J's legal controversies, investor group calls for split of Gorsky's CEO and chairman roles

03:01 AM • Clinical Trials ArenaCoronavirus treatment: Vaccines/drugs in the pipeline for Covid-19

03:00 AM • STATA detailed guide to the coronavirus drugs and vaccines in development